The Ascendancy of Yttrium-90 Radioembolization: Contemporary National Trends among Liver Transplant Candidates with Hepatocellular Carcinoma
Authors:
- Riad SalemRSRiad Salem
- Allison J. KwongAKAllison J. Kwong
- Edward KimEKEdward Kim
- Laura KulikLKLaura Kulik
- Neil MehtaNMNeil Mehta
- 4 September 2026
- journal article
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 37 (12)
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Consortium on Bridging Radiation Segmentectomy (COBRAS): A Multicenter Study of Complete Pathologic Necrosis in Hepatocellular CarcinomaRadiology, 2026
- Yttrium-90 radioembolization is associated with a lower risk of liver transplant waitlist dropout than chemoembolization in hepatocellular carcinomaJournal of Hepatology, 2026
- Yttrium-90 Radioembolization Has Become the Most Utilized Bridging Treatment for Liver Transplant Candidates in the United StatesJournal of Vascular and Interventional Radiology, 2024
- Radiation segmentectomy for curative intent of unresectable very early to early stage hepatocellular carcinoma (RASER): a single-centre, single-arm studyThe Lancet Gastroenterology & Hepatology, 2022